To sign up for our e-mail newsletter or print publications, fill out the information below and click Subscribe.
Grant D. Lawless, RPh, MD, FACP
Maryann Wahmann provides resources for neuroendocrine cancers.
Dr. Sanjiv Agarwala discusses the pros and cons of using Pembrolizumab over anti-CTLA4 antibody therapy.
Two-pronged attack on chemotherapy-resistant leukemia cells
An Early Look at Research From the 2016 ASCO Annual Meeting
Drug against breast cancer is also highly potent against a frequent form of leukaemia
Improving natural killer cancer therapy: Study